TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Pfizer AB
Closing information (x1000 DKK)
| Closing information | 2024/11 | 2023/11 | 2022/11 |
| Turnover |
1,259,971
|
1,399,240
|
2,850,910 |
| Financial expenses |
1,937
|
1,170
|
2,199 |
| Earnings before taxes |
41,619
|
76,397
|
29,961 |
| EBITDA |
42,213
|
75,384
|
153,126 |
| Total assets |
770,623
|
701,463
|
1,234,223 |
| Current assets |
756,720
|
682,556
|
1,218,408 |
| Current liabilities |
492,414
|
395,195
|
976,130 |
| Equity capital |
278,209
|
306,268
|
258,094 |
| - share capital |
23,121
|
23,288
|
24,303 |
| Employees (average) |
158
|
155
|
145 |
Financial ratios
| Fiscal year | 2024/11 | 2023/11 | 2022/11 |
| Solvency |
36.1%
|
43.7%
|
20.9% |
| Turnover per employee |
7,974
|
9,027
|
19,661 |
| Profit as a percentage of turnover |
3.3%
|
5.5%
|
1.1% |
| Return on assets (ROA) |
5.7%
|
11.1%
|
2.6% |
| Current ratio |
153.7%
|
172.7%
|
124.8% |
| Return on equity (ROE) |
15.0%
|
24.9%
|
11.6% |
| Change turnover |
-129,253
|
-1,332,516
|
2,394,666 |
| Change turnover % |
-9%
|
-49%
|
525% |
| Chg. No. of employees |
3
|
10
|
62 |
| Chg. No. of employees % |
2%
|
7%
|
75% |
Total value of public sale
| Fiscal year | 2024/11 | 2023/11 | 2022/11 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.